3.75 WATSON 363
Pill imprint 3.75 WATSON 363 has been identified as Clorazepate dipotassium 3.75 mg.
Clorazepate is used in the treatment of alcohol withdrawal; anxiety; seizure prevention and belongs to the drug class benzodiazepines. FDA has not classified the drug for risk during pregnancy.
Clorazepate 3.75 mg has a low potential for abuse. The drug has a currently accepted medical use in treatment in the United States. Abuse of the drug may lead to limited physical dependence or psychological dependence relative to the drugs in schedule 3.
See also related documents.
Clorazepate dipotassium Images
- Imprint:
-
3.75
WATSON 363 - Strength:
- 3.75 mg
- Color:
- Blue
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Benzodiazepines
- Pregnancy Category:
- N - Not yet classified
- CSA Schedule:
- 4 - Some potential for abuse
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-0363
| NDC Code | Manufacturer / Repackager |
|---|---|
| 63874-1242 | Altura Pharmaceuticals Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Clorazepate Dipotassium resources
- Clorazepate (Wolters Kluwer)
- Clorazepate Sustained-Release Tablets (Wolters Kluwer)
- clorazepate (Cerner Multum)
- Gen-Xene (Micromedex) - Includes Dosage Information
- clorazepate (Micromedex) - Includes Dosage Information
- Clorazepate Dipotassium (AHFS DI)
- Clorazepate (FDA)
- Clorazepate Dipotassium (Wolters Kluwer)
Search Again
